Joost Besseling

1.8k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Joost Besseling is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Joost Besseling has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 10 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cancer Research. Recurrent topics in Joost Besseling's work include Lipoproteins and Cardiovascular Health (19 papers), Cancer, Lipids, and Metabolism (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Joost Besseling is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Cancer, Lipids, and Metabolism (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers). Joost Besseling collaborates with scholars based in Netherlands, United States and Canada. Joost Besseling's co-authors include John J.P. Kastelein, G. Kees Hovingh, Barbara A. Hutten, Joep C. Defesche, Iris Kindt, Barbara Sjouke, Roeland Huijgen, Michel H. Hof, Jeanine E. Roeters van Lennep and Jacqueline de Graaf and has published in prestigious journals such as The Lancet, JAMA and Circulation.

In The Last Decade

Joost Besseling

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

2014 308 citations Barbara Sjouke, D. Meeike Kusters et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joost Besseling Netherlands	13	1.1k	497	382	259	241	26	1.3k
Roeland Huijgen Netherlands	23	1.2k 1.1×	470 0.9×	344 0.9×	341 1.3×	291 1.2×	44	1.5k
Paul Ziajka United States	11	1.0k 0.9×	499 1.0×	271 0.7×	315 1.2×	228 0.9×	18	1.3k
Ovidio Muñiz-Grijalvo Spain	19	966 0.9×	405 0.8×	344 0.9×	326 1.3×	168 0.7×	53	1.3k
Dick C.G. Basart Netherlands	8	819 0.7×	459 0.9×	250 0.7×	298 1.2×	177 0.7×	13	1.1k
Laurens F. Reeskamp Netherlands	20	907 0.8×	416 0.8×	335 0.9×	531 2.1×	136 0.6×	65	1.4k
Ilse K. Luirink Netherlands	13	673 0.6×	260 0.5×	187 0.5×	247 1.0×	141 0.6×	19	906
Ros Whittall United Kingdom	18	1.2k 1.1×	341 0.7×	393 1.0×	267 1.0×	134 0.6×	28	1.5k
Marta Futema United Kingdom	20	1.1k 1.0×	351 0.7×	400 1.0×	373 1.4×	131 0.5×	48	1.4k
M van Linde-Sibenius Trip Netherlands	8	706 0.6×	480 1.0×	216 0.6×	401 1.5×	122 0.5×	8	1.2k
J. Kastelein Netherlands	8	541 0.5×	312 0.6×	156 0.4×	161 0.6×	96 0.4×	28	785

Countries citing papers authored by Joost Besseling

Since Specialization

Citations

This map shows the geographic impact of Joost Besseling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joost Besseling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joost Besseling more than expected).

Fields of papers citing papers by Joost Besseling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joost Besseling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joost Besseling. The network helps show where Joost Besseling may publish in the future.

Co-authorship network of co-authors of Joost Besseling

This figure shows the co-authorship network connecting the top 25 collaborators of Joost Besseling. A scholar is included among the top collaborators of Joost Besseling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joost Besseling. Joost Besseling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Besseling, Joost, Thomas Klausch, Marije Slingerland, et al.. (2023). Assessing real-world representativeness of prospective registry cohorts in oncology: insights from patients with esophagogastric cancer. Journal of Clinical Epidemiology. 164. 65–75. 2 indexed citations

Besseling, Joost, et al.. (2022). Exercise and Nutritional Interventions in Patients with Advanced Gastroesophageal Cancer: A Systematic Review. Journal of Gastrointestinal Cancer. 54(3). 1006–1009. 4 indexed citations

Hartgers, Merel L., Joost Besseling, Erik S.G. Stroes, et al.. (2018). Achieved LDL cholesterol levels in patients with heterozygous familial hypercholesterolemia: A model that explores the efficacy of conventional and novel lipid-lowering therapy. Journal of clinical lipidology. 12(4). 972–980.e1. 17 indexed citations

Besseling, Joost, G. Kees Hovingh, Roeland Huijgen, John J.P. Kastelein, & Barbara A. Hutten. (2016). Statins in Familial Hypercholesterolemia. Journal of the American College of Cardiology. 68(3). 252–260. 129 indexed citations

Besseling, Joost, Johannes B. Reitsma, Daniel Gaudet, et al.. (2016). Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia. European Heart Journal. 38(8). ehw135–ehw135. 41 indexed citations

Hartgers, Merel L., Joost Besseling, & G. Kees Hovingh. (2016). Attainment of LDL-C treatment target in familial hypercholesterolemia patients: A theoretical model exploring efficacy of current and novel lipid lowering therapies. Atherosclerosis. 252. e43–e44. 1 indexed citations

Kastelein, John J.P., Joost Besseling, Sukrut Shah, et al.. (2015). Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study. The Lancet. 385(9983). 2153–2161. 80 indexed citations

Besseling, Joost, Roeland Huijgen, Seth S. Martin, et al.. (2015). Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Atherosclerosis. 246. 1–6. 5 indexed citations

Backer, Guy De, Joost Besseling, John Chapman, et al.. (2015). Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology. Atherosclerosis. 241(1). 169–175. 123 indexed citations

10.

Besseling, Joost, Barbara Sjouke, & John J.P. Kastelein. (2015). Screening and treatment of familial hypercholesterolemia – Lessons from the past and opportunities for the future (based on the Anitschkow Lecture 2014). Atherosclerosis. 241(2). 597–606. 29 indexed citations

11.

Besseling, Joost, Kwok Leung Ong, Roeland Huijgen, et al.. (2015). The impact of LDLR function on fibroblast growth factor 21 levels. Atherosclerosis. 241(2). 322–325. 1 indexed citations

12.

Besseling, Joost, Iris Kindt, Michel H. Hof, et al.. (2014). Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers. Atherosclerosis. 233(1). 219–223. 162 indexed citations

13.

Sjouke, Barbara, D. Meeike Kusters, Iris Kindt, et al.. (2014). HOMOZYGOUS AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN THE NETHERLANDS: PREVALENCE, GENOTYPE-PHENOTYPE RELATIONSHIP AND CLINICAL OUTCOME. Journal of the American College of Cardiology. 63(12). A2050–A2050. 28 indexed citations

14.

Sjouke, Barbara, D. Meeike Kusters, Iris Kindt, et al.. (2014). Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome. European Heart Journal. 36(9). 560–565. 308 indexed citations breakdown →

15.

Besseling, Joost, Barbara A. Hutten, John J.P. Kastelein, & G. Kees Hovingh. (2014). Lack of LDL-receptors protects against new onset type 2 diabetes - results of a cohort of 38,000 individuals analyzed for FH mutations. Atherosclerosis. 235(2). e15–e15.

16.

Jakulj, Lily, Joost Besseling, Erik S.G. Stroes, & Albert K. Groen. (2013). Intestinal cholesterol secretion: future clinical implications.. PubMed. 71(9). 459–65. 11 indexed citations

17.

Hovingh, Kees, Joost Besseling, & John J.P. Kastelein. (2013). Efficacy and safety of mipomersen sodium (Kynamro). Expert Opinion on Drug Safety. 12(4). 569–579. 24 indexed citations

18.

Besseling, Joost, et al.. (2013). LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?. Drugs. 73(4). 293–301. 19 indexed citations

19.

Besseling, Joost, G. Kees Hovingh, & E.S.G. Stroes. (2013). Antisense oligonucleotides in the treatment of lipid disorders: pitfalls and promises.. PubMed. 71(3). 118–22. 7 indexed citations

20.

Besseling, Joost, et al.. (1965). THE RAPID WARMING OF BLOOD FOR MASSIVE TRANSFUSION BY RADIO FREQUENCY INDUCTION.. PubMed. 39. 137–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact